arrow
L

Laurie A. Tomlinson

London School of Hygiene and Tropical Medicine
H指数:53
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland

作者更正:托珠单抗与萨利鲁单抗在因COVID-19住院的成人中的比较:英格兰和苏格兰的目标试验模拟

2026-11-040
OAAI
Factors associated with severe COVID-19 in immunocompromised subgroups in England from 2020 to 2024: an OpenSAFELY cohort study

2020年至2024年英格兰免疫抑制亚组中与重症COVID-19相关的因素:一项OpenSAFELY队列研究

2026-06-260
OAAI
Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland

托珠单抗与萨利尤单抗在因COVID-19住院的成人中的比较:英格兰和苏格兰的目标试验模拟

2026-05-150
OAAI
Renin-angiotensin system inhibitors (RASi) are not nephrotoxic - they protect the kidneys and the heart

肾素-血管紧张素系统抑制剂(RASi)并非肾毒性药物——它们保护肾脏和心脏

2026-05-011
OAAI
Outpatient hospital attendances in people with rheumatoid arthritis during the COVID-19 pandemic and beyond: a cohort study in three nations of the UK

COVID-19疫情期间及之后类风湿关节炎患者的门诊就诊情况:一项在英国三个国家的队列研究

2025-11-010
PRE
Healthcare utilisation in people with long COVID: an OpenSAFELY cohort study

长期COVID患者的医疗保健利用: 一项OpenSAFELY队列研究

2024-06-204
OAAI
Cardiorenal effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers among people underrepresented in trials: analysis of routinely collected data with emulation of a reference trial (ONTARGET)
2024-06-184
OAAI
Clinical coding of long COVID in primary care 2020-2023-2023 in a cohort of 19 million adults: an OpenSAFELY analysis

1900万名成年人初级保健2020 2023 2023长COVID的临床编码: 一项OpenSAFELY分析

2024-06-012
OAAI
Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)

长期COVID对健康相关生活质量的影响: 一项使用患者报告结果指标的开放式人群队列研究 (OpenPROMPT)

2024-05-0113
OA
Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational study using the OpenSAFELY-UKRR and SRR databases

sotrovimab和molnupiravir预防肾脏替代治疗患者严重新型冠状病毒肺炎结局的比较有效性: 使用OpenSAFELY-UKRR和SRR数据库的观察性研究

2023-08-292
OAAI
Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform
2023-07-012
OAAI
Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data

使用观察数据估计新型冠状病毒肺炎疫苗接种有效性的挑战

2023-05-0112
OA